Tag: Drug Approvals
FDA Approves HPV Vaccine for People Through Age 45
Updated vaccine designed to prevent cancers and disease caused by nine HPV types
FDA Approves New Treatment for Squamous Cell Carcinoma
Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
FDA Approves New Drug for Antibiotic-Resistant Lung Disease
Arikayce approved to treat lung disease caused by Mycobacterium avium complex bacteria
FDA Approves Device for Acute Coronary Artery Perforations
The PK Papyrus device is a balloon-expandable covered coronary stent and delivery system
FDA Approves Novel Treatment for Hairy Cell Leukemia
Lumoxiti, a CD22-directed cytotoxin, approved for adults who have had at least two prior therapies
FDA Approves New Treatment for Opioid Dependence
The sublingual buprenorphine and naloxone combo should be part of a complete treatment plan
FDA Approves First Drug for Neurotrophic Keratitis
Oxervate, a topical eye drop, led to complete corneal healing among 70 percent of study participants
FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma
Drug approved to treat relapsed or refractory mycosis fungoides and Sézary syndrome
FDA Approves Azedra for Rare Adrenal Tumors
First systemic treatment for patients who experience tumor-related symptoms such as hypertension
FDA Approves Magnetic System for Guiding Lymph Node Biopsies
Sentimag System uses magnetic detection to identify sentinel lymph nodes for surgical removal
